Company Monitoring Page for Retrophin

latest headlines for company on cafepharma

FDA sets back Travere's plans for kidney disease drug approval
Fierce Biotech
Wed, 05/26/21 - 10:50 am
Tags:
Travere Therapeutics, kidney disease, clinical trials, FDA, Retrophin, Martin Shkreli
Retrophin no more: Shkreli's legacy disappears as former company becomes Travere Therapeutics
Endpoints
Mon, 11/16/20 - 10:29 pm
Tags:
Retrophin, Martin Shkreli, Travere Therapeutics
Retrophin to buy Orphan Tech for $90M upfront
Seeking Alpha
Thu, 10/22/20 - 11:12 pm
Tags:
Retrophin, Orphan Tech, M&A, enzyme replacement
Top 7 Companies in Biotech Beach by Revenue
BioSpace
Thu, 12/5/19 - 10:15 am
Tags:
Biotech Beach, San Diego, California, Amgen, Neurocrine, Acadia Pharmaceuticals, Retrophin, Tocagen, Mirati Therapeutics, AnaptysBio
Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails
Xconomy
Thu, 08/22/19 - 11:15 am
Tags:
Retrophin, Martin Shkreli, fosmetpantotenate
Retrophin paid Martin Shkreli 'undisclosed sum' to settle yearslong legal disputes
Endpoints
Fri, 08/9/19 - 10:45 am
Tags:
Martin Shkreli, Retrophin
FDA Approves Retrophin’s New Formula for Cystine Kidney Stones
BioSpace
Mon, 07/1/19 - 07:36 pm
Tags:
Retrophin, FDA, kidney stones, cystinuria, cystine kidney stones, Thiola
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
Yahoo/Benzinga
Mon, 07/1/19 - 10:32 am
Tags:
Retrophin, Karyopharm, Celyad, uniQure, Sangamo Therapeutics, Catalyst Biosciences, Novo Nordisk, Reata Pharmaceuticals, Vertex Pharmaceuticals, Bellicum, Gilead Sciences, Jaguar Health, TRACON Pharmaceuticals, FibroGen, Aslan Pharma, ObsEva, Sorrento Therapeutics
FDA Action Alert: Regeneron, Sanofi, Celgene
BioSpace
Mon, 06/24/19 - 07:27 pm
Tags:
FDA, drug approvals, Acer Therapeutics, Edsivo, Regeneron, Sanofi, Dupixent, Celgene, Revlimid, Alexion, Soliris, Dova Pharmaceuticals, Doptelet, Nabriva Therapeutics, Contepo, Retrophin, Thiola
After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin
Endpoints
Fri, 06/21/19 - 09:53 am
Tags:
Martin Shkreli, Retrophin
Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues
Endpoints
Mon, 06/3/19 - 11:23 am
Tags:
Martin Shkreli, Retrophin
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
Sat, 06/1/19 - 12:52 pm
Tags:
FDA, Merck, Zerbaxa, XERIS, Gvoke HypoPen, Keytruda, Amag Pharmaceuticals, Palatin, Vyleesi, Acer Therapeutics, Edsivo, Sanofi, Regeneron, Dupixent, Alexion, Soliris, Retrophin, Thiola, Allergan, Botox
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Thu, 05/30/19 - 09:39 am
Tags:
Merck, Keytruda, Sanofi, Regeneron, Dupixent, Alexion, Soliris, FDA, Dova Pharmaceuticals, Retrophin
Made for TV: Shkreli running his drug company from prison cell, WSJ says
Fierce Pharma
Thu, 03/7/19 - 12:17 pm
Tags:
Martin Shkreli, Phoenixus, Retrophin
Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus
Endpoints
Wed, 03/7/18 - 11:58 am
Tags:
R&D, Martin Shkreli, RE-0024, Retrophin, Cyprus, clinical trials
From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives
Fierce Pharma
Sat, 07/15/17 - 11:33 am
Tags:
Martin Shkreli, fraud, Retrophin
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Endpoints
Fri, 07/7/17 - 10:36 am
Tags:
Martin Shkreli, biotech, Retrophin, fraud
Martin Shkreli’s former biotech company Retrophin is leaving Cambridge
Bizjournals.com
Fri, 03/10/17 - 09:39 am
Tags:
Retrophin, Cambridge, Martin Shkreli
Martin Shkreli in court as securities fraud case moves closer to trial
CNBC
Thu, 01/26/17 - 06:56 pm
Tags:
Martin Shkreli, securities fraud, Retrophin
4 Key BioPharma Movers in the Past Week
24/7 Wall St
Sun, 09/11/16 - 10:19 pm
Tags:
Retrophin, Evoke Pharma, Celgene, Lexicon Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.